PICO Portalanswers from OpenAlex & ORCID
Robert C. Bourge
ResearcherPublications, citations & collaboration network
Robert C. Bourge is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Robert C. Bourge have?
PICO Portalindexed works
Robert C. Bourge has 312 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Robert C. Bourge have?
PICO Portalcitation count
Robert C. Bourge has 24,912 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Robert C. Bourge?
PICO Portalh-index
Robert C. Bourge has an h-index of 70 in OpenAlex.
What is the i10-index of Robert C. Bourge?
PICO Portali10-index
Robert C. Bourge has an i10-index of 178 in OpenAlex.
What is the ORCID of Robert C. Bourge?
PICO Portalorcid
The ORCID for Robert C. Bourge is on the source record.
What is the OpenAlex record for Robert C. Bourge?
PICO Portalopenalex
The OpenAlex for Robert C. Bourge is on the source record.
What are the most-cited papers on Robert C. Bourge?
PICO Portalmost cited works
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
Robyn J. Barst, Lewis J. Rubin, Walker Long, Michael D. McGoon, Stuart Rich, David B. Badesch, Bertron Μ. Groves, Victor F. Tapson, Robert C. Bourge, Bruce H. Brundage, Spencer K. Koerner, David Langleben, Cesar A. Keller, Srinivas Murali, Barry F. Uretsky, Linda Clayton, Maria M. Jöbsis, Shelmer D. Blackburn, Denise Shortino, James W. Crow
Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial
William T. Abraham, Philip B. Adamson, Robert C. Bourge, Mark F. Aaron, Maria Rosa Costanzo, Lynne W. Stevenson, Warren Strickland, Suresh Neelagaru, Nirav Raval, Steven K. Krueger, Stanislav Weiner, David M. Shavelle, Bradley Jeffries, Jay S. Yadav
Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial
Gérald Simonneau, Robyn J. Barst, Nazzareno Galiè, Robert Naeije, Stuart Rich, Robert C. Bourge, Anne Keogh, Ronald J. Oudiz, Adaani Frost, Shelmer D. Blackburn, James W. Crow, Lewis J. Rubin
Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease
David B. Badesch, Victor F. Tapson, Michael D. McGoon, Bruce H. Brundage, Lewis J. Rubin, Fredrick M. Wigley, Stuart Rich, Robyn J. Barst, Pamela S. Barrett, Kenneth M. Kral, Maria M. Jöbsis, James E. Loyd, Srinivas Murali, Adaani Frost, Reda E. Girgis, Robert C. Bourge, David Ralph, C. Gregory Elliott, Nicholas S. Hill, David Langleben, Robert Schilz, Vallerie V. McLaughlin, Ivan M. Robbins, Bertron Μ. Groves, Shelley Shapiro, Thomas A. Medsger, Seán Gaine, Evelyn M. Horn, James C. Decker, Katharine Knobil
Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure
Wilson S. Colucci, Uri Elkayam, Darlene P. Horton, William T. Abraham, Robert C. Bourge, Allen D. Johnson, Lynne E. Wagoner, Michael M. Givertz, Chang‐seng Liang, Matthew Neibaur, W. Herbert Haught, Thierry H. LeJemtel